The company was founded in 2005 as a pharmaceutical industrialization platform that supports innovation at the source. Its core business focuses on product development, manufacturing and commercial operation of medical innovation achievements, and effectively optimizes medical scenarios through scientific and technological innovation. The company's main business is to provide overall commercial solutions for pharmaceutical product manufacturers, covering the three sectors of brand operation, wholesale distribution and retail. Main products or businesses: Operates brands such as Diqao series, Hale series, Takeda series, Roche series, Keonis, Esnona, Neutschuma, Atricure, Fuzhenghua, Zisheng, etc.; distributes pharmaceuticals, Chinese medicine tablets, medical devices, diagnostic reagents, medical consumables, etc.; sells pharmaceuticals, medical devices, health food, cosmetics, etc. Corporate honors: Top 50 service enterprises in Shandong in 2021, the first batch of Chinese OTC brand clusters, 2021 Pharmaceutical Industry “13th Five-Year” Enterprise Management Award - Outstanding Growth Enterprise, certified by Euromonitor as “No. 1 in the domestic imported calcium supplement market for eight consecutive years”, and won honors such as the “Nursery Network” Orange Product of the Year Top 10 Pharmaceutical and Nutritional Products for Popular Mom Products of the Year.
No Data
No Data